跳至主要内容
临床试验/NCT07057297
NCT07057297招募中不适用

Residual Stenosis and Restenosis Following Carotid Endarterectomy With Primary Closure, A Prospective Tracking Study

Charles University, Czech Republic1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2025年2月1日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
300
试验地点
1
主要终点
Restenosis ≥50% at 12 months

研究概览

简要总结

This prospective, multicenter observational study aims to evaluate the incidence, timing, and characteristics of residual and recurrent (restenosis) carotid artery stenosis following carotid endarterectomy (CEA) with primary closure. Conducted across several neurosurgical centers in the Czech Republic, the study will include patients undergoing elective CEA who meet standard clinical indications.

Participants will undergo preoperative CT angiography and follow-up imaging at 30 days and 1 year post-surgery. Residual stenosis is defined as ≥50% luminal narrowing detected within 30 days postoperatively, while restenosis is evaluated at later time points. The study will also assess clinical outcomes such as ischemic stroke, TIA, myocardial infarction, and mortality. The standardized surgical technique and harmonized diagnostic algorithm across all centers aim to provide robust data on the performance and durability of primary closure CEA.

详细描述

Study Objective:

The objective of this study is to assess the true incidence of restenosis following CEA in the Czech Republic. A major advantage of this study is the use of standardized surgical procedures across participating centers, along with unified data collection methods and diagnostic algorithms.

Methodology:

Patient Cohort:

All patients meeting the current guideline indications for CEA will be enrolled.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients without matching any of exclusion criteria who underwent cartotid endarterectomy

排除标准

  • Age ≤18 or ≥90 years
  • Previous endarterectomy or stenting
  • Unsuitable vascular anatomy
  • High perioperative risk
  • Contralateral cranial nerve X or XII palsy
  • History of neck irradiation
  • Tandem carotid stenosis or intracranial vascular pathology (e.g., aneurysm or AVM)
  • Absence of signed informed consent

结局指标

主要结局

Restenosis ≥50% at 12 months

时间窗: 12 months

Restenosis ≥50% at 12 months

次要结局

  • Restenosis ≥50%(30 days)
  • iCMP/TIA/death/MI(1 year)
  • Change in modified Rankin Scale (mRS)(1 year)

研究者

发起方
Charles University, Czech Republic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Norbert Svoboda

cpt. MD. Norbert Svoboda, PhD., FEBNS

Charles University, Czech Republic

研究点 (1)

Loading locations...

相似试验